The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers - Article

Purpose Currently, the FDA allows biowaivers for Class I (high solubility and high permeability) and Class III (high solubility and low permeability) compounds of the Biopharmaceutics Classification System (BCS). Scientific evidence should be provided to support biowaivers for BCS Class I and Class III (high solubility and low permeability) compounds. Methods Data on the effects of excipients on drug permeability are needed to demonstrate that commonly used excipients do not affect the permeability of BCS Class III compounds, which would support the application of biowaivers to Class III compounds. This study was designed to generate such data by assessing the permeability of four BCS Class III compounds and one Class I compound in the presence and absence of five commonly used excipients. 

More

Download
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers
art%3A10.1007%2Fs11095-015-1773-4.pdf
Adobe Acrobat Document 545.0 KB